There was blood in the streets for cannabis investors today thanks to profit-taking and increased correlation within the sector since the launch of the ETFMG Alternative Harvest ETF (NYSE:MJX). Out of over 200+ marijuana stocks, here are 3 of the only marijuana stock winners in trading on Thursday, February 1st including Digipath, Inc. (OTC:DIGP) and more...
Shares of Digipath, Inc. rose 8.11% on the OTC markets on higher than average trading volume, closing the day at $0.30 per share. Today, the company announced that it has resumed cannabis testing operations following the reinstatement of the Medical Marijuana Registration Certificate and Marijuana Testing Facility License.
Shares of Heliospectra AB rose 8.75% on the OTC markets on lower than average trading volume, closing the day at $0.87 per share. Recently, the company announced an order from the University of Adelaide.
Shares of Skinvisible, Inc. rose 15.000% on the OTC markets on higher than average trading volume, closing the day at $0.023 USD per share. Recently, the company announced that it has entered into a non-binding term sheet regarding a proposed merger of Skinvisible, Inc. with and into Quoin Pharmaceuticals Limited.
Tell us which marijuana stocks put you in the green today! Join the conversation in our Marijuana Stock Forum!
Conclusion
Find more about today's gainers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!
D/M/O
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
